Westlake Chemical Partners (WLKP) EBT (2013 - 2026)

Westlake Chemical Partners' EBT history runs 14 years deep, the most recent figure standing at $81.8 million for Q1 2026.

• Quarterly EBT rose 92.93% year-over-year to $81.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $338.5 million (up 4.96% YoY) and the FY2025 annual result came in at $299.1 million, down 19.15% from the prior year.
• EBT was $81.8 million for Q1 2026 at Westlake Chemical Partners, down from $84.5 million in the prior quarter.
• Across five years, EBT topped out at $104.3 million in Q3 2024 and bottomed at $42.4 million in Q1 2025.
• A 5-year average of $83.7 million and a median of $86.0 million in 2025 frame the typical range for EBT.
• Annual changes were most pronounced in 2025 — EBT slumped 52.8% — and 2026, when it jumped 92.93%.
• Westlake Chemical Partners' EBT stood at $91.5 million in 2022, then dropped by 4.58% to $87.3 million in 2023, then increased by 0.37% to $87.6 million in 2024, then slipped by 3.58% to $84.5 million in 2025, then slipped by 3.1% to $81.8 million in 2026.
• Business Quant data shows WLKP's EBT at $81.8 million in Q1 2026, $84.5 million in Q4 2025, and $86.3 million in Q3 2025.